Sign in
4

Changes in Ownership

Xenon Pharmaceuticals Inc. Filed Acc 0001193125-26-009235

Options or other derivatives

  • Chief Commercial Officer acquired 60,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Cline Darren S · Chief Commercial Officer

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2026-01-09 Grant or award : show line 1 in the form Share Option (Right to Buy) +40,000 40,000 D
2026-01-09 Grant or award : show line 2 in the form Restricted Share Units +20,000 20,000 D
Loading xslF345X05/ownership.xml…